Cyclosporin in the treatment of idiopathic nephrotic syndrome in children. 1987

P Niaudet, and R Habib, and M J Tete, and N Hinglais, and M Broyer
Service de Néphrologie Pédiatrique, Hôpital Necker Enfants-Malades, Paris, France.

Thirty-five children (12 girls, 23 boys), aged from 1 year and 5 months to 14 years at the onset of idiopathic nephrotic syndrome, received cyclosporin A (CyA) because of steroid toxicity or failure to respond to steroids. The initial oral dose was 6 mg/kg per day and this was adjusted to obtain trough plasma levels of 50-150 ng/ml. The duration of treatment was between 2 and 8 months. In patients who responded to CyA treatment, the dosage was tapered off; treatment was stopped if found to be ineffective. Of the 35 children, 20 were frequent-relapsing steroid responders who suffered serious side-effects from steroid therapy. Seventeen of them either went into remission or did not relapse despite the withdrawal of prednisone. Prednisone doses could be lowered but not stopped in 1 patient and the remaining 2 patients relapsed when prednisone was tapered off. At the final examination, 10 of the 12 children in whom CyA was tapered off and who had initially responded to CyA had relapsed. A second course was given to these 10 patients and 3 failed to respond. Five children were partial steroid responders and CyA induced a remission in 1 and a partial remission in another. Among the 10 children who were steroid resistant, only 1 responded to CyA, 2 had a partial response and 7 failed to respond to CyA. A reduction of glomerular filtration rate occurred in 8 patients, 7 of whom had either persistent nephrotic syndrome or were in relapse, which suggests that factors other than CyA nephrotoxicity may have been operative. Complete reversal occurred in only 4 patients. Significant histological changes, likely to be related to CyA, were seen in 2 repeat renal biopsies out of the 11 performed.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Niaudet, and R Habib, and M J Tete, and N Hinglais, and M Broyer
September 1992, Nederlands tijdschrift voor geneeskunde,
P Niaudet, and R Habib, and M J Tete, and N Hinglais, and M Broyer
January 1997, Journal of nephrology,
P Niaudet, and R Habib, and M J Tete, and N Hinglais, and M Broyer
June 1991, Anales de medicina interna (Madrid, Spain : 1984),
P Niaudet, and R Habib, and M J Tete, and N Hinglais, and M Broyer
September 1997, Anales espanoles de pediatria,
P Niaudet, and R Habib, and M J Tete, and N Hinglais, and M Broyer
September 1986, Lancet (London, England),
P Niaudet, and R Habib, and M J Tete, and N Hinglais, and M Broyer
January 1987, Springer seminars in immunopathology,
P Niaudet, and R Habib, and M J Tete, and N Hinglais, and M Broyer
October 2012, Clinics (Sao Paulo, Brazil),
P Niaudet, and R Habib, and M J Tete, and N Hinglais, and M Broyer
January 1995, Contributions to nephrology,
P Niaudet, and R Habib, and M J Tete, and N Hinglais, and M Broyer
January 1995, Contributions to nephrology,
P Niaudet, and R Habib, and M J Tete, and N Hinglais, and M Broyer
September 1992, Nederlands tijdschrift voor geneeskunde,
Copied contents to your clipboard!